Literature DB >> 35084672

Permissive role of Na+/H+ exchanger isoform 1 in migration and invasion of triple-negative basal-like breast cancer cells.

Xiuju Li1, Larry Fliegel2.   

Abstract

In breast cancer, it is the resulting metastasis that is the primary cause of fatality. pH regulatory proteins and the tumor microenvironment play an important role in metastasis of cancer cells and acid-extruding proteins are critical in this process. There are several types of breast cancer and triple-negative breast cancer tends to be more metastatic and invasive and is itself is composed of several types. MDA-MB-468 are a triple-negative breast cancer cell line and are classified as basal-like and basal tumors account for up to 15% of breast cancers. Here we examined the effect of removal of the acid-extruding protein, the Na+/H+ exchanger isoform one, from MDA-MB-468 cells. NHE1 was deleted from these cells using the CRISPR/Cas9 system. Western blotting and measurement of activity confirmed the absence of the protein. In wounding/cell migration experiments, deletion of NHE1 reduced the rate of cell migration in the presence of low- or high-serum concentrations. Anchorage-dependent colony formation was also greatly reduced by deletion of the NHE1 protein. Cell proliferation was not affected by knockout of NHE1. The results demonstrate that NHE1 has an important role in migration and invasion of basal-like triple-negative breast cancer cells.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Basal tumors; Breast cancer; Colony formation; Migration; Na+/H+ exchanger; pH regulation

Mesh:

Substances:

Year:  2022        PMID: 35084672     DOI: 10.1007/s11010-022-04370-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Outcomes and recurrence patterns according to breast cancer subtypes in Korean women.

Authors:  Yoontaek Lee; Eunyoung Kang; Angela Soeun Lee; Hyunnam Baek; Eun-Kyu Kim; So Yeon Park; Jee Hyun Kim; Yu Jung Kim; Se Hyun Kim; In Ah Kim; Keun-Yong Eom; Sung-Won Kim
Journal:  Breast Cancer Res Treat       Date:  2015-04-17       Impact factor: 4.872

3.  The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.

Authors:  Ezia Bello; Giulia Taraboletti; Gennaro Colella; Massimo Zucchetti; Daniele Forestieri; Simonetta A Licandro; Alexander Berndt; Petra Richter; Maurizio D'Incalci; Ennio Cavalletti; Raffaella Giavazzi; Gabriella Camboni; Giovanna Damia
Journal:  Mol Cancer Ther       Date:  2012-12-27       Impact factor: 6.261

Review 4.  Breast cancer metastasis: markers and models.

Authors:  Britta Weigelt; Johannes L Peterse; Laura J van 't Veer
Journal:  Nat Rev Cancer       Date:  2005-08       Impact factor: 60.716

Review 5.  Treatment of metastatic breast cancer: state-of-the-art, subtypes and perspectives.

Authors:  Nagi S El Saghir; Arafat Tfayli; Hassan A Hatoum; Zahi Nachef; Phuong Dinh; Ahmad Awada
Journal:  Crit Rev Oncol Hematol       Date:  2011-02-16       Impact factor: 6.312

6.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 7.  Breast cancer as a systemic disease: a view of metastasis.

Authors:  A J Redig; S S McAllister
Journal:  J Intern Med       Date:  2013-08       Impact factor: 8.989

Review 8.  Choosing the right cell line for breast cancer research.

Authors:  Deborah L Holliday; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2011-08-12       Impact factor: 6.466

9.  Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Authors:  Harri Sihto; Johan Lundin; Mikael Lundin; Tiina Lehtimäki; Ari Ristimäki; Kaija Holli; Liisa Sailas; Vesa Kataja; Taina Turpeenniemi-Hujanen; Jorma Isola; Päivi Heikkilä; Heikki Joensuu
Journal:  Breast Cancer Res       Date:  2011-09-13       Impact factor: 6.466

10.  Patterns of distant metastasis in Chinese women according to breast cancer subtypes.

Authors:  San-Gang Wu; Jia-Yuan Sun; Li-Chao Yang; Li-Ying Tang; Xue Wang; Xue-Ting Chen; Gui-Hua Liu; Huan-Xin Lin; Qin Lin; Zhen-Yu He
Journal:  Oncotarget       Date:  2016-07-26
View more
  1 in total

Review 1.  Extracellular Vesicles and Cell Pathways Involved in Cancer Chemoresistance.

Authors:  Lara Console; Mariafrancesca Scalise
Journal:  Life (Basel)       Date:  2022-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.